Many diseases have been associated with excessive iron in the liver. Therefore, the non-invasive detection of liver iron overload and the monitoring of iron chelation therapy is highly desirable. Presented here is a method to demonstrate the feasibility of this using MR-based $$$R^{*}_{2}$$$ and magnetic susceptibility quantification. Significant increases in $$$R^{*}_{2}$$$ and susceptibility (Glass’ Δ values in the ranges of [-4.29 -3.23] and [-2.55 -2.23], respectively) are observed in iron overloaded livers in comparison to baseline measurements. After six doses of Polyrotaxane conjugated with Deferoxamine (rPR-DFO) iron chelation therapy administered over twelve days, Δ values of 0.13 and -0.09 are observed for $$$R^{*}_{2}$$$ and susceptibility, respectively, indicating that the differences are no longer significant and the treatment is effective.
This abstract and the presentation materials are available to members only; a login is required.